Skip Navigation

European Journal of Heart Failure 2005 7(3):423-428; doi:10.1016/j.ejheart.2005.01.001
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Stewart, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Financial aspects of heart failure programs of care

Simon Stewart*

Division of Health Sciences, University of South Australia Adelaide, Australia
Faculty of Health Sciences, University of Queensland Brisbane, Australia

* School of Nursing and Midwifery, City East Campus, University of South Australia, North Terrace, Adelaide, 5000, Australia. Tel.: +61 8 8302 1115; fax: +61 8 8302 1806. E-mail address: simon.stewart{at}unisa.edu.au


   Abstract

As suggested by studies that have examined the economic burden imposed by heart failure and, more specifically where the greatest expenditure occurs, the key to cost-effectively minimising the impact of a sustained heart failure epidemic is to minimise recurrent hospital use—even at the expense of increasing levels of community-based care and prescribed pharmacotherapy [Mark DB. Economics of treating heart failure. Am J Cardiol 1997;80:33H–38H; Weintraub WS, Cole J, Tooley JF. Cost and cost-effectiveness studies in heart failure research. Am Heart J 2002;143:565–76]. This paper examines the potential cost–benefits of applying specialist heart failure programs of care and the range of financial issues that need to be considered when establishing a formal heart failure service.

Key Words: Chronic heart failure • Programs of care • Cost

Received May 18, 2004; Revised December 20, 2004; Accepted January 4, 2005


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
D.-L. Dixon, C. G. De Pasquale, H. R. De Smet, S. Klebe, S. Orgeig, and A. D. Bersten
Reduced Surface Tension Normalizes Static Lung Mechanics in a Rodent Chronic Heart Failure Model
Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 181 - 187.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
U C Hoppe, M Vanderheyden, H Sievert, M C Brandt, R Tobar, W Wijns, and Y Rozenman
Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study
Heart, July 1, 2009; 95(13): 1091 - 1097.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
K. R. Beich and C. Yancy
The Heart Failure and Sodium Restriction Controversy: Challenging Conventional Practice
Nutr Clin Pract, October 1, 2008; 23(5): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
H. Patel, M. Shafazand, I. Ekman, S. Hojgard, K. Swedberg, and M. Schaufelberger
Home care as an option in worsening chronic heart failure-- A pilot study to evaluate feasibility, quality adjusted life years and cost-effectiveness
Eur J Heart Fail, July 1, 2008; 10(7): 675 - 681.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Yao, N. Freemantle, M. J. Calvert, S. Bryan, J.-C. Daubert, and J. G.F. Cleland
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator
Eur. Heart J., January 1, 2007; 28(1): 42 - 51.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. C. Inglis, S. Pearson, S. Treen, T. Gallasch, J. D. Horowitz, and S. Stewart
Extending the Horizon in Chronic Heart Failure: Effects of Multidisciplinary, Home-Based Intervention Relative to Usual Care
Circulation, December 5, 2006; 114(23): 2466 - 2473.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
S. Stewart
Review: multidisciplinary interventions reduce hospital admission and all cause mortality in heart failure
Evid. Based Nurs., January 1, 2006; 9(1): 23 - 23.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. J. Calvert, N. Freemantle, G. Yao, J. G.F. Cleland, L. Billingham, J.-C. Daubert, S. Bryan, and on behalf of the CARE-HF Investigators
Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial
Eur. Heart J., December 2, 2005; 26(24): 2681 - 2688.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.